Ginkgo bioworks stocks.
Jul 13, 2022 · Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ...
Ginkgo Bioworks' stock was trading at $1.69 at the start of the year. Since then, DNA shares have decreased by 15.4% and is now trading at $1.43. View the best growth stocks for 2023 here.Ginkgo Bioworks Holdings Inc stock has a Growth Score of 24, Estimate Revisions Score of 29 and Quality Score of 13. Comparing Ideaya Biosciences Inc and Ginkgo Bioworks Holdings Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your …This week was one to forget for Ginkgo Bioworks ( DNA 10.85%) shareholders. In the Monday-to-Friday period, their investment lost slightly more than 8% of its value on the stock market, according ...About Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food ...Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ...
Ginkgo Bioworks Holdings (NYSE: DNA) is owned by 57.45% institutional shareholders, 14.28% Ginkgo Bioworks Holdings insiders, and 28.27% retail investors. Cascade Investment LLC is the largest individual Ginkgo Bioworks Holdings shareholder, owning 151.87M shares representing 7.17% of the company.Those are some eye-opening estimates, particularly since the leader in synthetic biomanufacturing, Ginkgo Bioworks (DNA 2.16%), currently has a market cap of $6 billion and trades for a little ...
What happened. Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share …
Under the terms of the merger agreement entered into on July 24, 2022, Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo Class A common stock ...Ginkgo Bioworks (DNA 5.80%) is also a holding in the Ark Innovation ETF and the Ark Genomic Revolution ETF. The company is a leader in cell programming technology that's used in developing ...The all-stock deal values Zymergen at $300 million market capitalization, a far cry from its roughly $3 billion valuation at its initial public offering last April. Zymergen, which sought to use ...Ginkgo Bioworks Holdings Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50. On average, analysts rate DNA stock stock as …
A great way to start is by following her into a few exciting stock market stories. Just recently, she bought shares of Moderna ( MRNA 2.74%), Intuitive Surgical ( ISRG 1.40%), and Ginkgo Bioworks ...
Ginkgo Bioworks (DNA 8.53%) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood. Wood's confidence in ...
Ginkgo Bioworks stock plunged as much as 24% on Wednesday after a short-seller report from Scorpion Capital alleged that the synthetic biology company is a "Frankenstein mash-up of the worst frauds." The Ginkgo Bioworks stock price fell by -3.50% on the last day (Wednesday, 22nd Nov 2023) from $1.43 to $1.38. During the last trading day the stock fluctuated 8.82% from a day low at $1.36 to a day high of $1.48. The price has risen in 5 of the last 10 days but is still down by -7.38% for this period. Volume has increased on the …Nov 29, 2023 · Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $299,400, According to a Recent SEC Filing. MT. Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $112,837, According to a Recent SEC Filing. MT. Summary. Quotes. Charts. See Ginkgo Bioworks Holdings, Inc. (DNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.8,194,680. Aug 04 05:01 PM. open in yahoo open in reuters | open in marketwatch open in google open in EDGAR. DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.Many SPACs haven't lived up to their initial hype; unfortunately, Ginkgo hasn't been an exception. When its shares first began trading on the NYSE on Sept. 17, 2021, it opened …
1,292. Jason Kelly. https://www.ginkgobioworks.com. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from Bitome, an Integrated Metabolite Monitoring Platform. [16] [ self-published source ] On 25 July …Ginkgo Bioworks Company Info. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and ...When shares of innovative growth stocks like Ginkgo Bioworks ( DNA -4.79%) plummet, cunning investors know that there could be opportunity in the air. So even if a company like Ginkgo is down by ...Ginkgo Bioworks. Wood has dipped her toes into the nascent eTVOL industry, but she's already ankle-deep in Ginkgo Bioworks' (DNA-2.52%) biofoundry platform. After the company bought millions more ...Barron's 400. Research & Ratings. U.S.: NYSE. About Ginkgo Bioworks Holdings Inc. Research & Ratings. Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes ...
Get Ginkgo Bioworks Holdings Inc (DNA) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Under the terms of the merger agreement entered into on July 24, 2022, Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo Class A common stock. Zymergen shares will no longer be traded on Nasdaq. GinkgoClass A common stock will continue to trade on NYSE under the ticker …
The firm is now DNA stock's largest shareholder. Ginkgo Bioworks (NYSE: DNA) is in the red today, despite a recent transaction with $182 billion investment firm Baillie Gifford. Based on an ...Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Boston-based Ginkgo Bioworks (NYSE: DNA) is working to develop a platform to “program cells to make everything from food to materials to therapeutics.” Industries it serves include agriculture ...Ginkgo Bioworks stock plunged as much as 24% on Wednesday after a short-seller report from Scorpion Capital alleged that the synthetic biology company is a "Frankenstein mash-up of the worst frauds."Oct 19, 2022 · Under the terms of the merger agreement entered into on July 24, 2022, Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo Class A common stock. Zymergen shares will no longer be traded on Nasdaq. GinkgoClass A common stock will continue to trade on NYSE under the ticker symbol DNA. A great way to start is by following her into a few exciting stock market stories. Just recently, she bought shares of Moderna ( MRNA 2.74%), Intuitive Surgical ( ISRG 1.40%), and Ginkgo Bioworks ...
Get the latest Ginkgo Bioworks (DNA+) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Aug 18, 2021 · While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections.
The honeymoon for newly minted Ginkgo Bioworks ( DNA 4.11%) shares recently came to an abrupt end, and it didn't take long. The synthetic-biology start-up just made its stock market debut in mid ...Ginkgo Bioworks (DNA-3.47%) helps companies produce bio-engineered products that can be game changers in their respective industries. One example includes working with marijuana producer Cronos ...Oct 6, 2021 ... In about an hour following the publication of Scorpion's 175-page report, Ginkgo's stock price dropped at least 20%, down to about $9.50 a share ...Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock quote, history, news and other vital information to help you with your stock trading and investing.Sep 1, 2023 · Next-generation biotech Ginkgo Bioworks Holdings ( DNA -3.50%) was one of the star stocks in its sector this week. According to data compiled by S&P Global Market Intelligence, the company's share ... According to the issued ratings of 5 analysts in the last year, the consensus rating for Ginkgo Bioworks stock is Hold based on the current 1 sell rating, 3 hold ratings and 1 buy rating for DNA. The average twelve-month price prediction for Ginkgo Bioworks is $3.19 with a high price target of $6.00 and a low price target of $1.25. Learn more ...The latest Ginkgo Bioworks Holdings stock prices, stock quotes, news, and DNA history to help you invest and trade smarter.Shares of Ginkgo Bioworks ( NYSE: DNA) added ~10% pre-market Tuesday after the cell platform company and Google Cloud, a unit of tech giant Alphabet Inc. ( NASDAQ: GOOG) ( NASDAQ: GOOGL ...Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ...When shares of innovative growth stocks like Ginkgo Bioworks ( DNA -4.79%) plummet, cunning investors know that there could be opportunity in the air. So even if a company like Ginkgo is down by ...
Which Ginkgo Bioworks insiders have been buying company stock? The following insider purchased DNA shares in the last 24 months: Shyam Sankar ($512,000.00). How much insider buying is happening at Ginkgo Bioworks?A high-level overview of Ginkgo Bioworks Holdings, Inc. (DNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the fourth quarter and year ended ...Instagram:https://instagram. budweizer stockwhat is the best financial planning softwarebest technology mutual funds 2023lowest peg ratio stocks Stock Info; SEC Filings. SEC Filings; Quarterly Reports; Annual Reports; Sustainability; Governance. Executive Management; Board of Directors; Committee …Feb 24, 2023 · Ginkgo Bioworks ( DNA -7.19%) is a biotech that's operating on multiple bleeding edges of innovation as it works to engineer and manufacture biological cells at scale. Between its highly automated ... the best gold fundsfotball table Principal Financial Group Inc. increased its position in shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA – Free Report) by 38.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 122,835 shares of the company’s stock after acquiring an additional …Ginkgo Bioworks Holdings has a market cap or net worth of $3.03 billion as of December 1, 2023. Its market cap has decreased by -21.13% in one year. ... is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding. Formula: Market Cap = Stock Price * Shares ... stocks on cash app under dollar1 Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. ... Ginkgo Bioworks Holdings Inc (NYSE:DNA) Real-Time Quotes. 1.39. Jul 13, 2022 · Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ... 2. Ginkgo Bioworks. Ginkgo Bioworks ( DNA -7.19%) also plans to be a collaboration-driven business, but its approach is a bit different. While it uses its machine learning platform to help with ...